Pitt+Me - Pitt+Me

Interested in COVID-19 research study opportunities? Please view the COVID-19 Studies page for adults and the Pediatric Studies page for children aged birth-17.

To view all research studies currently recruiting participants, visit our new Featured Research page for adults and Featured Pediatric Research page for children. Please note that COVID-19 precautions are in place on the University of Pittsburgh campus. If you have questions or concerns about an upcoming research study visit, or if you have symptoms of COVID-19 or have been exposed to COVID-19, please contact the study team directly for additional information prior to your research study visit. Need help with your Pitt+Me account? Contact us.

View

Interested in COVID-19 research study opportunities? Please view the COVID-19 Studies page for adults and the Pediatric Studies page for children aged birth-17.

Welcome to the Allergies Studies Page

CURRENT STUDIES THAT MAY INTEREST YOU

EPITOPE Study – Toddlers Aged 1-3 with Peanut Allergy

Are you the parent of a 1-3 year old who has a peanut allergy? If so, you may be able to participate in the “EPITOPE” research study to find out if an investigational new drug, a novel desensitization method, called EPicutaneous ImmunoTherapy (EPIT) with the Viaskin® Peanut patch is safe and effective for children with peanut allergies.

AGE:

1 - 3

DURATION: About 60 weeks
VISITS: 12 visits

LOCATION:

UPMC Children’s Hospital of Pittsburgh

RELATED RESEARCH AREAS:

Immune System/Infections